Why the study?
Do calcium antagonist vasodilators improve renal sodium excretion and vasodilation compared to noncalcium antagonist vasodilators in animal models?
Do calcium antagonist vasodilators improve renal sodium excretion and vasodilation compared to noncalcium antagonist vasodilators in animal models?
Calcium antagonist vasodilators induce natriuresis and renal vasodilation, unlike noncalcium antagonists which cause antinatriuresis and vasoconstriction, potentially explaining differences in tolerance development.
Answers are grounded in this paper and cite their sources.
May explain vasodilator tolerance differences in animals; hypothesis-generating for human hypertension trials.
The effects of calcium antagonist and noncalcium antagonist vasodilator antihypertensive agents were examined using renal clearance, hemodynamic, and micropuncture techniques in anesthetized normotensive dogs, rats, and conscious spontaneously hypertensive rats. At doses that either failed to affect mean arterial pressure or lowered it equally, the calcium antagonist vasodilator agents nifedipine and felodipine produced a natriuresis and renal vasodilatation whereas the noncalcium antagonist vasodilator agents hydralazine and minoxidil produced an antinatriuresis and renal vasoconstriction. These findings support the view that the development of tolerance to the antihypertensive effect of noncalcium antagonist vasodilators, which is usually reversed by concomitant diuretic administration, is dependent on renal sodium and water retention. In addition, the capacity of calcium antagonist vasodilators to directly inhibit renal tubular sodium reabsorption explains their natriuretic action and the absence of antinatriuresis may contribute to lesser development of tolerance.
No takes yet. Share an insight, caveat, or question.
Gerald F. DiBona (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: